Home  >  Health Check  >  Could the flu vaccine protect against severe Covid-19?
Health Check
Could the flu vaccine protect against severe Covid-19?
Health Check
Jul 21, 2021

A really intriguing finding on flu vaccines - that they might offer some protection not just against flu, but against the most serious effects of Covid-19 – even though it is of course a completely different virus. Claudia Hammond talks to Dr Devinder Singh who led the research using anonymous medical records from countries including Singapore, Germany, Italy and Israel, which medical researchers can use.

Summer viruses And why are some countries in the middle of the summertime, seeing a surge of infections with viruses usually found in winter? In the northern hemisphere there are fears that we’ll see a surge of cases of flu next winter – a twindemic. Why is that? And is this something that will follow the seasons around the world? We hear from Lorna and her daughter Willow on Willow’s persistent cough and from Dr Michelle Jacobs who’s a consultant in paediatric and adult emergency medicine at Watford General Hospital in the UK on concerns of RSV and viral wheeze, and Tracy Hussell, professor in immunology at the University of Manchester on children’s long-term immunity especially for babies who are seeing all these infections for the first time.

Downs Syndrome and Covid-19 There’s new research just published in the British Medical Journal looking at how both adults and children with Downs Syndrome have been affected if they contract Covid. Some countries such as India are prioritising vaccination against Covid-19 for adults with Downs Syndrome. University College London’s Professor Monica Lakhanpaul’s work has been instrumental in helping clinics to start vaccinating people in India. And in the UK it’s just been announced that children with Downs Syndrome will be able to get vaccinated, which isn’t the case for all children. Monica explains the relevance of the research and her work in highlighting the issue.

Image: Vaccine bottles in a row Credit: Helder Faria/Getty Images

Presenter: Claudia Hammond Producer: Erika Wright

More Episodes


Mar 25, 2026
Antimicrobial resistance in conflict zones

For the last few weeks, the news has been dominated by the situation in the Middle East. Joining Claudia Hammond is BBC Health Correspondent James Gallagher who speaks with Dr Antoine Abou Fayad, a microbiologist and medicinal chemist based in Beirut, Lebanon. He reveals that war, just like the ongoing conflict in the Middle East, provides the perfect storm to accelerate the spread of multidrug-resistant infections. And nobody is safe.

Following the recent meningitis B outbreak in the UK which has killed two people and led to the rollout of vaccines and preventative antibiotics, Claudia and James discuss how meningitis outbreaks are dealt with in the ‘meningitis belt’ - an area stretching across 26 sub-Saharan African countries and talk about a new vaccine aiming to stop deadly meningitis epidemics which has been confirmed to be safe following analysis of vaccination campaigns in Nigeria and Niger.

And India's snakebite crisis is killing near sixty thousand people every year, about six people every hour. Journalist Chhavi Sachdev joins us to discuss the progress of India’s National Action Plan to tackle snakebite envenoming which launched two years ago. Also, what time of day do you exercise? Well, a new study using Fitbit-derived heart rate data has found that people who regularly exercised early in the morning were significantly less likely to have coronary artery disease, high blood pressure, Type 2 diabetes or obesity compared with people who exercised later in the day.

Presenter: Claudia Hammond Producer: Jonathan Blackwell


26min 28sec

Mar 18, 2026
Does your home country impact your cancer risk?

North Korean defectors and lifelong South Korean residents have significantly different cancer rates, despite their genetic similarities; new research finds. Presenter Laura Foster unpacks this study, explaining what it tells us about how upbringing and environment contribute to different cancer rates, and how migration can change these risks.

A new study has found GLP-1s – drugs typically used to treat diabetes and obesity – could have an unexpected benefit for patients dealing with substance abuse disorders. Laura speaks with Ziyad Al-Aly, a clinical epidemiologist and Veterans Affairs physician at Washington University in St Louis to understand what this could mean for treating drug and alcohol addictions, and what questions still need answers before this treatment can be rolled out.

Last weekend, Kenya’s National Environment Management Authority rolled out new waste management rules to better dispose of products containing plastic, but the new laws are expected to increase the price of sanitary pads by 20%. Global health reporter based in Nairobi, Dorcas Wangira joins Laura to unpack what these policies mean for the accessibility of sanitary products, and what alternative solutions are needed to balance access with environmental impact. They also discuss how a drug to treat Parkinson’s disease can be made from waste plastic bottles using a pioneering method.

And Jane Chambers reports from Peru about the growing prevalence of anaemia, speaking to local healthcare workers about what steps families can be taken to help their children recover.

Presenter: Laura Foster Producers: Jonathan Blackwell and Georgia Christie


26min 28sec

Could the flu vaccine protect against severe Covid-19?

--:--
--:--